Centre for Infectious Disease Epidemiology and Research - CIDER

Current areas of research include:
 

• Cohort studies of HIV treatment, evaluating individual treatment projects, provincial and national programs, and the co-hosting of a regional data centre for collaborative HIV cohort research in Southern Africa (IeDEA-SA), and a global data centre for paediatric HIV treatment cohorts (CIPHER)
   
• Population-level surveillance of infectious disease interventions in the Western Cape Province
   
• Novel service delivery approaches to the prevention of mother-to-child transmission (PMTCT) of HIV, and the identification of gaps in PMTCT services and optimal strategies to minimise these gaps
   
• Health systems research projects including evaluating models of care for HIV service delivery, models of HIV/TB service integration, and issues around task shifting and the use of lay health workers to support infectious diseases services.
   
• Mathematical modeling of HIV, TB, HPV and other infectious diseases and their prevention and treatment
   
• Context-appropriate information systems to monitor HIV, TB and PMTCT service delivery
   
• Collaboration on birth cohort studies

 CIDER staff are actively involved in policy processes and advisory groups, provincially, nationally and globally, including:
 

• Staff who are jointly appointed as public health specialists with the Western Cape Department of Health, with service responsibilities in surveillance and impact evaluations
   
• CIDER provides support to the HIV, AIDS, STI and tuberculosis (HAST) directorate in the Provincial Department of Health both through the joint appointees and through a long standing Global Fund grant to support routine HAST information systems
   
• Staff serve on provincial and national HIV guideline committees, and regularly participate in WHO reference groups on HIV treatment, PMTCT, and HIV information systems development
   
• CIDER works closely with a number of civil society organisations including a long standing collaboration with Médecins Sans Frontières, and the South African National AIDS Council
   
• CIDER develop and maintain one of the key information systems used for monitoring HIV and tuberculosis treatment in South Africa (Three Interlinked Electronic Registers – TIER.Net), and provide support to users of the system in ten other countries

 

The African Health Information Exchange (AHIE) Project

 

In late 2016 CIDER was awarded a grant from the Bill and Melinda Gates Foundation to establish a reference African Health Information Exchange (AHIE). The aim was to deliver a replicable and context-appropriate implementation of a health information exchange for clinical data, working across national and provincial health departments in South Africa. An important outcome of this would be successful interoperability implementations for key systems that were critical to the HIV and TB response in South Africa. The AHIE project was undertaken by a consortium led by UCT CIDER. Consortium members were the National Department of Health (NDoH), the Council for Scientific and Industrial Research (CSIR), Jembi Health Systems, and the South African National Health Laboratory Service (NHLS).  AHIE Video

The components of AHIE were:
 

HPRS: The scale up of the national health identifier and patient registration system, the Health Patient Registration System (HPRS) led by NDoH. Development of the HPRS was done by a team at the CSIR.  HPRS Video
 

PHDC: The maturation of a set of technologies that could harmonize person-level health data and enable disease cascade reporting from diagnosis through to treatment success to assist patient management at all levels of the health system. The Western Cape Provincial Health Data Centre (PHDC) would serve as the innovation incubator for this component.  PHDC Video

OpenHIM: The consolidation of a standards-based health information exchange (HIE) by adapting and maturing an open interoperability layer, the Open Health Information Mediator (OpenHIM), into a robust standards-based technology stack for widespread adoption.  OpenHIM Video

SPV: The development of a viewing application for clinicians to access consolidated longitudinal clinical data, the single patient viewer (SPV).  SPV Video

TIER.Net: The adaptation of TIER.Net to interoperate with other systems such as the HPRS and the NHLS laboratory information system. TIER.Net is an HIV and TB patient information system developed by CIDER and is used from facility level through to national level in about 4,000 facilities in South Africa.  TIER Video

Exciting outcome of AHIE – The OpenIHP:

As software development work progressed throughout the AHIE project, it became clear that there was a need for an online solution to manage and monitor treatment of patients with HIV and TB. A dynamic data-driven forms engine was added to SPV that enabled the capture of new data to complement and be integrated with existing data in the PHDC, enabling users to view and capture on the same platform, reducing the need to import data from a separate, stand-alone system.

This new converged software platform is called the Open Integrated Health Platform (OpenIHP). Convergence to OpenIHP means that the PHDC, SPV, TIER.Net and enterprise reporting functionality can now be replicated and supported as one consolidated platform. In 2020 the effectiveness and adaptability of OpenIHP was successfully established and the platform has been playing an important role in the Western Cape Province’s response to COVID-19.  OpenIHP Video

Emma Kalk, Associate Professor and Director             Email:  Emma.Kalk@uct.ac.za Phone:  021 406 6074 Publications Emma Kalk is a Clinical Epidemiologist in the Centre for Infectious Disease Epidemiology & Research where she manages projects linked to maternal and child health. She has a medical background in paediatric HIV clinical studies. The main focus of her current research has been the impact of HIV and ART in vertical transmission of HIV; this has expanded to include all pregnancy exposures with a special interest in pharmacovigilance during pregnancy and breast-feeding. Dr Kalk is also involved in projects designed to support a population-based database which links operational health data sources and sentinel site-based implementation science studies (most recently, this has included the Western Cape Pregnancy Exposure Registry). She collaborates nationally and within Africa.

Mary-Ann Davies, Professor             Email:  Mary-Ann.Davies@uct.ac.za Phone:  021 406 6051 Publications Mary-Ann Davies is a Public Health Medicine Specialist and Paediatric Clinical Epidemiologist at the University of Cape Town, where she is Director of the Centre for Infectious Disease Epidemiology and Research (CIDER). She convenes the MPH module on Infectious Disease Epidemiology. She is joint Principal Investigator of IeDEA Southern Africa, together with Matthias Egger from the University of Bern in Switzerland. Here major research interests are paediatric HIV treatment and prevention, especially HIV cohort research to address key policy and implementation questions.

Andrew Boulle, Professor                 Email:  Andrew.Boulle@uct.ac.za Phone:  021 406 6715 Publications Andrew Boulle is a Public Health Medicine specialist with the Western Cape Provincial Department of Health and Professor of Public Health Medicine at the University of Cape Town.  His research has predominantly addressed operational and clinical questions related to HIV service provision, often through analyses of HIV cohorts or population-based analyses.  A further focus is context-appropriate information systems development in health care and the use and harmonisation of person-level health data for service and patient benefit.  He currently provides oversight for the Provincial Health Data Centre in the Provincial Department of Health and leads the African Health Information Exchange consortium which brings together organisations working on interoperability and technical solutions in support of services for HIV and tuberculosis. Research Groups Centre for Infectious Disease Epidemiology and Research (CIDER) Wellcome Centre for Infectious Disease Research in Africa (CIDRI-Africa) Health Intelligence Initiative (HII) Teaching Public Health Medicine specialist training MBChB - Public Health undergraduate teaching semesters 3 and 4 MPH - Infectious Disease Epidemiology PhD, MMed and MPH supervision

Landon Myer, Professor and Head of Division: Epidemiology and Biostatistics                 Email:  Landon.Myer@uct.ac.za Phone:  021 406 6661 Publications Landon Myer is Head of the Division of Epidemiology and Biostatistics. He has training in social anthropology, clinical medicine and epidemiology. His research focuses on women's, maternal and child health in the context of HIV. He has lead multiple clinical and health systems studies investigating the health of HIV-infected women receiving ART during pregnancy and postpartum, as well as the health and development of HIV-exposed and -infected children and adolescents.

Leigh Johnson, Associate Professor             Email:  Leigh.Johnson@uct.ac.za Phone:  021 406 6981 Publications Leigh Johnson is an epidemiologist and actuary, working at the Centre for Infectious Disease Epidemiology and Research (University of Cape Town). His research interests are in modelling of HIV and other infectious diseases, and most of his published work has focused on evaluating the impact of HIV prevention and treatment programmes in South Africa. He is the lead developer of the Thembisa model, a combined HIV and demographic model developed for South Africa (see www.thembisa.org). He is a member of the International Epidemiology Databases to Evaluate AIDS (IeDEA) collaboration and the UNAIDS Reference Group on Estimates, Modelling and Projections. He is also an editor of the journals AIDS and Infectious Disease Modelling.

Ushma Mehta, Associate Professor and Deputy Director Email:  Ushma.Mehta@uct.ac.za Phone:  021 650 1558

Mpho Tlali, Clinical Research Officer Email:  Mpho.Tlali@uct.ac.za Phone:  021 650 4550

Morna Cornell, Senior Research Officer                 Email:  Morna.Cornell@uct.ac.za Phone:  021 406 6487 Publications Morna Cornell is Senior Research Officer at the Southern African IeDEA (International Epidemiology Databases to Evaluate AIDS) data centre based in the Centre for Infectious Disease Epidemiology (CIDER), School of Public Health. Morna has worked in HIV/AIDS since 1992, as Director of the AIDS Consortium, as a consultant for the Western Cape Department of Health, and subsequently as project manager of the CIPRA-SA (Comprehensive International Programme of Research on HIV/AIDS) programme.

Reshma Kassanjee, Senior Research Officer                 Email:  Reshma.Kassanjee@uct.ac.za Phone:  021 650 7194 Publications Dr Reshma Kassanjee is a statistician at the Centre for Infectious Disease Epidemiology and Research (CIDER), and a member of the International Epidemiology Databases to Evaluate AIDS (IeDEA) collaboration. Reshma has a background in both mathematical statistics and computational and applied mathematics, and is most passionate about their contribution to public health and epidemiology. She spent a number of years developing methodologies and generating key results to support the estimation of HIV incidence. Her primary focus is infectious disease surveillance, and she aims both to provide answers to topical patient- and population-level questions, as well as to advance the required methodologies and tools, all with the goal of better informing decision making.

Carl Morrow,  Senior Research Officer Email:  carl.morrow@uct.ac.za

Meg Osler, Senior Research Officer       Email:  meg.osler@uct.ac.za Phone:  021 406 6717 Publications Meg Osler is a Senior Technical Advisor for Strategic Information and stewards the development of the TIER.Net health information system being used in multiple countries in Africa. In addition, Meg continues her work as a PhD candidate considering the impact of policies on morbidity and mortality within the HIV services. Meg Osler's interests lie in improving health information ecosystems and using the resulting population-level data to improve patient management and service delivery.

Kim Anderson, Research Officer             Email:  kim.anderson@uct.ac.za Phone:  021 406 6602 Publications Kim Anderson is a clinical epidemiologist at CIDER and a member of the International Epidemiology Databases to Evaluate AIDS (IeDEA) collaboration. She has a medical background in paediatic and adolescent HIV medicine. Her research areas of interest include health outcomes in perinatally-HIV-infected children and adolescents, morbidity in HIV-exposed uninfected children and prevention of mother-to-child transmission of HIV.  Dr Anderson chairs the Global Paediatric Working Group for the IeDEA consortium, a global consortium of HIV care programmes.

 Research Officers

Name	Email	Telephone No
Jonathan Euvrard		021 406 6636
Patience Nyakato		021 404 7737
Gem Patten		021 406 6482

Project Managers

Name	Email	Telephone No
Nontobeko Tena-Coki		021 650 2406
Wendy Wiemers

Data Scientists

Name	Email	Telephone No
Chido Chinogurei
Alexa Heekes
Nicola Maxwell		021 406 6602
Themba Mutemaringa
Mariette Smith		021 406 6482

Software Managers

Name	Email	Telephone No
Robin Burley		021 406 6937
Prakash Buddiga

Honorary Senior Lecturers

David Pienaar

Michael Schomaker

Honorary Research Associate

Gilles van Cutsem

Centre Manager

Name	Email	Telephone No
Carmelita Sylvester		021 406 6808

Research Administrators

Name	Email	Telephone No
Karin van Wyk		021 650 2316

2024

• Anderson K, van Zyl G, Hsiao NY, Claassen M, Mudaly V, Voget J, Heekes A, Kalk E, Phelanyane F, Boulle A, Sridhar G. HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South Africa. The Pediatric Infectious Disease Journal. 2024:10-97.
• Anderson K, Kalk E, Heekes A, Phelanyane F, Jacob N, Boulle A, Mehta U, Kassanjee R, Sridhar G, Ragone L, Vannappagari V. Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis. Journal of the International AIDS Society. 2024 Mar;27(3):e26235.
• Allorant A, Muset P, Hodgins C, Kirakoya-Samadoulougou F, Namachapa K, Mbofana F, Panagiotoglou D, Johnson LF, Imai-Eaton JW, Maheu-Giroux M. Temporal trends and determinants of HIV testing at antenatal care in Sub-Saharan Africa: a pooled analysis of population-based surveys (2005–2021). JAIDS Journal of Acquired Immune Deficiency Syndromes. 2024 Jan 1;95(1S):e97-105.
• Chihana M, Conan N, Ohler L, Huerga H, Wanjala S, Masiku C, Szumilin E, Ellman T, Etard JF, Maman D, Davies MA. Changes Over Time in the Proportion of Advanced HIV Disease in Two High HIV Prevalence Settings in Ndhiwa (Kenya) and Eshowe (South Africa). Journal of the International Association of Providers of AIDS Care (JIAPAC). 2024 Jun;23:23259582241260219.
• Chinogurei C, Manne-Goehler J, Kahn K, Kabudula CW, Cornell M, Rohr JK. Socio-Behavioural Barriers to Viral Suppression in the Older Adult Population in Rural South Africa. AIDS and Behavior. 2024 Apr 15:1-7.
• Davey DL, Nyemba DC, Mvududu R, Mashele N, Johnson L, Bekker LG, Dean SS, Bheemraj K, Coates TJ, Myer L. Pregnancy outcomes following self-reported and objective-measured exposure to oral preexposure prophylaxis in South Africa. Aids. 2024 Jan 1;38(1):75-83.
• De Beer ST, Davies MA, Phelanyane F, Jones HE, Ingle SM, Eley BS, Anderson K, Heekes A, Kalk E, Mendelsohn A, Boulle A. The Retrospective Implementation of Standardized In Utero HIV Exposure Definitions Using Routinely Collected Public Sector Data Across the Western Cape Province, South Africa. The Pediatric Infectious Disease Journal. 2024 Jul 24:10-97
• Fernandez Villalobos NV, Ruffieux Y, Haas AD, Chinogurei C, Cornell M, Taghavi K, Egger M, Folb N, Maartens G, Rohner E. Cervical precancer and cancer incidence among insured women with and without HIV in South Africa. International journal of cancer. 2024 Jan 15;154(2):273-83.
• Glaubius R, Stover J, Johnson LF, Mahiane SG, Mahy MI, Eaton JW. Differences in breastfeeding duration by maternal HIV status: a pooled analysis of nationally representative surveys in Sub-Saharan Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2024 Jan 1;95(1S):e81-8.
• Hunter M, Peters S, Khumalo N, Davies MA. Analysis of patient flow and barriers to timely discharge from general medical wards at a tertiary academic hospital in Cape Town, South Africa. BMC Health Services Research. 2024 Mar 6;24(1):287.
• Hussey H, Vreede H, Davies MA, Heekes A, Kalk E, Hardie D, van Zyl G, Naidoo M, Morden E, Bam JL, Zinyakatira N. SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities. PLOS Global Public Health. 2024 Aug 6;4(8):e0003554.
• Jacob N, Rice B, Heekes A, Johnson LF, Brinkmann S, Kufa T, Puren A, Boulle A. Exploring the validity of routine individuated service data for antenatal HIV surveillance in the Western Cape. Research Square. 2024 Mar 21.
• Johnson LF, Kassanjee R, Folb N, Bennett S, Boulle A, Levitt NS, Curran R, Bobrow K, Roomaney RA, Bachmann MO, Fairall LR. A model-based approach to estimating the prevalence of disease combinations in South Africa. BMJ Global Health. 2024 Feb 1;9(2):e013376.
• Johnson L, White P, Jeevan R, Browne J, Gulliver-Clarke C, O'Donoghue J, Mohiuddin S, Hollingworth W, Fairbrother P, MacKenzie M, Holcombe C. Long-term outcomes of mastectomy with and without delayed breast reconstruction: A population cohort study. European Journal of Surgical Oncology. 2024 Feb 1;50(2).
• Kalk E, Heekes A, Lavies D, Jacobs L, Spencer C, Boutall A, Osman A, Stewart C, Davies MA, van Niekerk A, Fieggen K. Population‐based prevalence of congenital defects in a routine sentinel site‐based surveillance system in the Western Cape, South Africa. Birth Defects Research. 2024 Aug;116(8):e2388.
• Kassanjee R, Davies MA, Heekes A, Mahomed H, Hawkridge AJ, Wolmarans M, Morden E, Jacobs T, Cohen C, Moultrie H, Lessells RJ. COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022. medRxiv. 2024:2024-01.
• Kehoe K, Morden E, Jacobs T, Zinyakatira N, Smith M, Heekes A, Murray J, le Roux DM, Wessels T, Richards M, Eley B. Comparison of paediatric infectious disease deaths in public sector health facilities using different data sources in the Western Cape, South Africa (2007–2021). BMC Infectious Diseases. 2023 Feb 22;23(1):104.
• Korenromp EL, Sabin K, Stover J, Brown T, Johnson LF, Martin-Hughes R, Ten Brink D, Teng Y, Stevens O, Silhol R, Arias-Garcia S. New HIV infections among key populations and their partners in 2010 and 2022, by world region: a multisources estimation. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2024 Jan 1;95(1S):e34-45.
• Meehan SA, Hesseling AC, Boulle A, Chetty J, Connell L, Dlamini-Miti NJ, Dunbar R, Du Preez K, George G, Hoddinott G, Jennings K. Reducing initial loss to follow-up among people with bacteriologically confirmed tuberculosis: LINKEDin, a quasi-experimental study in South Africa. InOpen Forum Infectious Diseases 2024 Jan (Vol. 11, No. 1, p. ofad648). US: Oxford University Press
• Meehan SA, Hesseling AC, von Delft A, Marx FM, Hughes JA, Bock P, Banke-Thomas A, Dunbar R, Phelanyane F, Smith M, Osman M. Association between tuberculosis and pregnancy outcomes: a retrospective cohort study of women in Cape Town, South Africa. BMJ open. 2024 Feb 1;14(2):e081209.
• Mesa-Vieira C, Didden C, Schomaker M, Mouton JP, Folb N, van den Heuvel LL, Gastaldon C, Cornell M, Tlali M, Kassanjee R, Franco OH. Post-traumatic stress disorder as a risk factor for major adverse cardiovascular events: a cohort study of a South African medical insurance scheme. Epidemiology and psychiatric sciences. 2024 Jan;33:e5.
• Mutai KK, Stone J, Scheibe A, Fraser H, Johnson LF, Vickerman P. Trends and factors associated with illicit drug use in South Africa: Findings from multiple national population-based household surveys, 2002–2017. International Journal of Drug Policy. 2024 Mar 1;125:104352.
• Ruffieux Y, Fernandez Villalobos NV, Didden C, Haas AD, Chinogurei C, Cornell M, Egger M, Maartens G, Folb N, Rohner E. Prostate cancer diagnosis rates among insured men with and without HIV in South Africa: a cohort study. Cancer Epidemiology, Biomarkers & Prevention. 2024 May 7.
• Nyakato P, Boulle A, Wood R, Eley B, Rabie H, Egger M, Yiannoutsos CT, Davies MA, Cornell M. Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial Records. The Pediatric Infectious Disease Journal. 2024 May 1;43(5):430-6
• Nyakato P, Schomaker M, Boulle A, Euvrard J, Wood R, Eley B, Prozesky H, Christ B, Anderegg N, Ayakaka I, Rafael I. Correcting mortality estimates among children and youth on antiretroviral therapy in southern Africa: A comparative analysis between a multi‐country tracing study and linkage to a health information exchange. Tropical Medicine & International Health. 2024 Jul 4.
• Phillips TK, Kassanjee R, Maxwell N, Anderson K, Johnson L, Moolla H, Myer L, Chi BH, Euvrard J, Boulle A, Davies MA. ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013–2019): a retrospective cohort study. Journal of the International AIDS Society. 2024 Apr;27(4):e26236.
• Plaisy MK, Minga AK, Wandeler G, Murenzi G, Samala N, Ross J, Lopez A, Mensah E, de Waal R, Kuniholm MH, Diero L. Metabolic causes of liver disease among adults living with HIV from low‐and middle‐income countries: a cross‐sectional study. Journal of the International AIDS Society. 2024 Apr;27(4):e26238.
• Rautenbach SP, Whittles LK, Meyer-Rath G, Jamieson L, Chidarikire T, Johnson LF, Imai-Eaton JW. Future HIV epidemic trajectories in South Africa and projected long-term consequences of reductions in general population HIV testing: a mathematical modelling study. The Lancet Public Health. 2024 Apr 1;9(4):e218-30.
• Robson I, Mphande M, Lee J, Hubbard JA, Daniels J, Phiri K, Chikuse E, Coates TJ, Cornell M, Dovel K. Implementing a male‐specific ART counselling curriculum: a quality assessment with healthcare workers in Malawi. Journal of the International AIDS Society. 2024 Jul;27(7):e26270.
• Silhol R, Anderson RL, Stevens O, Stannah J, Booton RD, Baral S, Dimitrov D, Mitchell KM, Donnell D, Bershteyn A, Brown T. Measuring HIV acquisitions among partners of key populations: estimates from HIV transmission dynamic models. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2024 Jan 1;95(1S):e59-69
• Slogrove AL, Bovu A, de Beer S, Phelanyane F, Williams PL, Heekes A, Kalk E, Mehta U, Theron G, Abrams EJ, Cotton MF. Maternal and birth outcomes in pregnant people with and without HIV in the Western Cape, South Africa. AIDS. 2024 Jan 1;38(1):59-67.
• Stevens O, Anderson R, Stover J, Teng Y, Stannah J, Silhol R, Jones H, Booton RD, Martin-Hughes R, Johnson L, Maheu-Giroux M. Comparison of empirically derived and model-based estimates of key population HIV incidence and the distribution of new infections by Population Group in Sub-Saharan Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2024 Jan 1;95(1S):e46-58.
• Thomas ML, Zuma K, Loykissoonlal D, Dube ZB, Vranken P, Porter SE, Kripke K, Seatlhodi T, Meyer-Rath G, Johnson LF, Imai-Eaton JW. Substantial but spatially heterogeneous progress in male circumcision for HIV prevention in South Africa. Communications Medicine. 2024 Jan 3;4(1):1.
• Thorp M, Balakasi K, Khan S, Stillson C, van Oosterhout JJ, Nichols BE, Cornell M, Dovel K. Men’s Satisfaction with General Health Services is Associated with Future Use of HIV Testing in Malawi: A Community-Representative Survey. AIDS and Behavior. 2024 Jun 13:1-1.
• Trickey A, Johnson LF, Bonifacio R, Kiragga A, Howard G, Biraro S, Wagener T, Low A, Vickerman P. Investigating the Associations between Drought, Poverty, High-Risk Sexual Behaviours, and HIV Incidence in Sub-Saharan Africa: A Cross-Sectional Study. AIDS and Behavior. 2024 Feb 20.
• Trickey A, Glaubius R, Pantazis N, Zangerle R, Wittkop L, Vehreschild J, Grabar S, Cavassini M, Teira R, Monforte AD, Casabona J. Estimation of improvements in mortality in spectrum among adults with HIV receiving antiretroviral therapy in high-income countries. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2024 Jan 1;95(1S):e89-96.
• Tsondai PR, Davies MA, Singtoroj T, Maxwell N, Technau KG, Chokephaibulkit K, Lumbiganon P, Sohn AH, Global fRAmework of Data collection Used for Adolescent HIV Transition Evaluation (GRADUATE) Advisory Group. Creating a data collection and management platform to support measurement of adolescent HIV care transition processes within low-and middle-income countries. PLOS Global Public Health. 2024 Aug 5;4(8):e0002705.van Schalkwyk C, Mahy M, Johnson LF, Imai-Eaton JW. Updated Data and Methods for the 2023 UNAIDS HIV Estimates. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2024 Jan 1;95(1S):e1-4.
• van Vollenhoven H, Kalk E, Kroon SM, Maseko T, Phelanyane F, Euvrard J, Fourie L, le Roux N, Nongena P. Effects of the COVID-19 pandemic on early infant diagnosis of HIV in Cape Town, South Africa. Southern African Journal of HIV Medicine. 2024 Mar 18;25(1):1542.
   

2023

• Kubjane M, Cornell M, Osman M, Boulle A, Johnson LF. Drivers of sex differences in the South African adult tuberculosis incidence and mortality trends, 1990–2019. Scientific Reports. 2023 Jun 10;13(1):9487.

• Cassidy T, Cornell M, Makeleni B, Horsburgh CR, Duran LT, de Azevedo V, Boulle A, Fox MP. Attrition from Care Among Men Initiating ART in Male-Only Clinics Compared with Men in General Primary Healthcare Clinics in Khayelitsha, South Africa: A Matched Propensity Score Analysis. AIDS and Behavior. 2023 Jan;27(1):358-69.

• Davies MA, Morden E, Rousseau P, Arendse J, Bam JL, Boloko L, Cloete K, Cohen C, Chetty N, Dane P, Heekes A. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA. 4 and BA. 5 compared with previous waves in the Western Cape Province, South Africa. International Journal of Infectious Diseases. 2023 Feb 1;127:63-8.

• Anderson K, Iyun V, Eley BS, Rabie H, Ferreira T, Nuttall J, Frigati L, Van Dongen N, Davies MA. Hospitalization among infants who initiate antiretroviral therapy before 3 months of age. AIDS. 2023 Mar 1;37(3):435-45.

• Patten GE, Euvrard J, Anderegg N, Boulle A, Arendse KD, von der Heyden E, Ford N, Davies MA. Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model. AIDS. 2023 Mar 1;37(3):513-22.

• Maugans C, Loveday M, Hlangu S, Waitt C, Van Schalkwyk M, van de Water B, Salazar-Austin N, McKenna L, Mathad JS, Kalk E, Hurtado R. Best practices for the care of pregnant people living with TB. The International Journal of Tuberculosis and Lung Disease. 2023 May 1;27(5):357-66.

• Leke AZ, Malherbe H, Kalk E, Mehta U, Kisa P, Botto LD, Ayede I, Fairlie L, Maboh NM, Orioli I, Zash R. The burden, prevention and care of infants and children with congenital anomalies in sub-Saharan Africa: A scoping review. PLOS Global Public Health. 2023 Jun 28;3(6):e0001850.

• Johnson LF, Kubjane M, de Voux A, Ohrnberger J, Tlali M. An agent-based model of binge drinking, inequitable gender norms and their contribution to HIV transmission, with application to South Africa. BMC Infectious Diseases. 2023 Jul 29;23(1):500.

• Bidzha ML, Johnson LF, Dorrington RE, Ngepah N, Greyling T. The impact of child mortality on fertility in South Africa: Do child support grants and antiretroviral treatment matter?. Plos one. 2023 Apr 4;18(4):e0284032.

• Vreeman RC, Yiannoutsos CT, Yusoff NK, Wester CW, Edmonds A, Ofner S, Davies MA, Leroy V, Lumbiganon P, de Menezes Succi RC, Twizere C. Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. BMJ open. 2023 Mar 1;13(3):e069399.

• Slogrove AL, Davies MA, Phelanyane F, De Beer S, Theron G, Williams PL, Abrams EJ, Cotton MF, Boulle A. Hypertensive disorders of pregnancy and HIV: analysis of a province-wide cohort during 2018 and 2019. AIDS (London, England). 2023 Jun 6;37(7):1047.

• Mnguni AT, Schietekat D, Ebrahim N, Sonday N, Boliter N, Schrueder N, Gabriels S, Sigwadhi LN, Zemlin AE, Chapanduka ZC, Ngah V. The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital. BMC Infectious Diseases. 2023 Feb 28;23(1):123.

• Dovel KL, Hariprasad S, Hubbard J, Cornell M, Phiri K, Choko A, Abbott R, Hoffman R, Nichols B, Gupta S, Long L. Strategies to improve antiretroviral therapy (ART) initiation and early engagement among men in sub‐Saharan Africa: A scoping review of interventions in the era of universal treatment. Tropical Medicine & International Health. 2023 May 2.

• de Waal R, Rabie H, Technau KG, Eley B, Sipambo N, Cotton M, Boulle A, Wood R, Tanser F, Fatti G, Egger M. Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts. Antiviral therapy. 2023 Apr 11;28(2):13596535231168480.

• Kassanjee R, Davies MA, Ngwenya O, Osei‐Yeboah R, Jacobs T, Morden E, Timmerman V, Britz S, Mendelson M, Taljaard J, Riou J. COVID‐19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa. Journal of the International AIDS Society. 2023 Jun;26(6):e26104.

• Lewis L, Sookrajh Y, van der Molen J, Khubone T, Maraj M, Sosibo P, van Heerden R, Little F, Kassanjee R, Garrett N, Dorward J. Long‐term usage patterns and clinical outcomes in a community‐based differentiated antiretroviral therapy delivery programme in South Africa. Journal of the International AIDS Society. 2023 Jul;26(7):e26141.

• Nyambayo PP, Gold MS, Mehta UC. Data Driven vigiPoint Identification Study of Adverse Event Reporting Patterns for Zimbabwe Reports in VigiBase WHO Global Database of Individual Case Safety Reports for Medicines and Vaccines. Fortune Journal of Health Sciences. 2023;6(2):237-45.

• Choko AT, Coates TJ, Mphande M, et al. Engaging men through HIV self-testing with differentiated care to improve ART initiation and viral suppression among men in Malawi (ENGAGE): A study protocol for a randomized control trial. PLoS One 2023; 18: e0281472. 20230224. DOI: 10.1371/journal.pone.0281472.

• Fernández Villalobos NV, Ruffieux Y, Haas AD, et al. Cervical precancer and cancer incidence among insured women with and without HIV in South Africa. Int J Cancer 2023 20230902. DOI: 10.1002/ijc.34707.

• Haeri Mazanderani AF, Murray TY, Johnson LF, et al. Eliminating Vertical Transmission of HIV in South Africa: Establishing a Baseline for the Global Alliance to End AIDS in Children. Diagnostics (Basel) 2023; 13 20230801. DOI: 10.3390/diagnostics13152563.

• Mphande M, Robson I, Hubbard J, et al. Developing a male-specific counselling curriculum for HIV treatment in Malawi. medRxiv 2023 20230810. DOI: 10.1101/2023.08.08.23293583.

• Mutemaringa T, Heekes A, Smith M, et al. Record linkage for routinely collected health data in an African health information exchange. Int J Popul Data Sci 2023; 8: 1771. 20230228. DOI: 10.23889/ijpds.v6i1.1771.

• Patten G, Sipambo N, Technau KG, et al. Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa. J Acquir Immune Defic Syndr 2023; 92: 273-280. DOI: 10.1097/qai.0000000000003137.

• Ruffieux Y, Wettstein A, Maartens G, et al. Life years lost associated with mental illness: A cohort study of beneficiaries of a South African medical insurance scheme. J Affect Disord 2023; 340: 204-212. 20230806. DOI: 10.1016/j.jad.2023.08.013.
• Saito M, McGready R, Tinto H, et al. Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis. Lancet 2023; 401: 118-130. 20221125. DOI: 10.1016/s0140-6736(22)01881-5.

• Slogrove AL, de Beer ST, Kalk E, et al. Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort study. BMJ Open 2023; 13: e070465. 20230102. DOI: 10.1136/bmjopen-2022-070465.

• Stone J, Bothma R, Gomez GB, et al. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis. J Int AIDS Soc 2023; 26: e26063. DOI: 10.1002/jia2.26063.
• Thorp M, Bellos M, Temelkovska T, et al. Mobility and ART retention among men in Malawi: a mixed-methods study. J Int AIDS Soc 2023; 26: e26066. DOI: 10.1002/jia2.26066.

• Haas AD, Lienhard R, Didden C, et al. Mental Health, ART Adherence, and Viral Suppression Among Adolescents and Adults Living with HIV in South Africa: A Cohort Study. AIDS Behav 2023; 27: 1849-1861. 20230102. DOI: 10.1007/s10461-022-03916-x.

• Vadlamudi NK, Basham CA, Johnston JC, et al. The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review. PLOS Glob Public Health 2023; 3: e0002163. 20230719. DOI: 10.1371/journal.pgph.0002163.

 

2022

• Nyemba DC, Kalk E, Vinikoor MJ, Madlala HP, Mubiana-Mbewe M, Mzumara M, Moore CB, Slogrove AL, Boulle A, Davies MA, Myer L. Growth patterns of infants with in-utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia. BMC Public Health. 2022 Dec;22:1-4.

• Conan N, Simons E, Chihana ML, Ohler L, FordKamara E, Mbatha M, VanCutsem G, Huerga H. Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?. PLoS One. 2022 Mar 24;17(3):e0265488.

• Le Tourneau N, Germann A, Thompson RR, Ford N, Schwartz S, Beres L, Mody A, Baral S, Geng EH, Eshun-Wilson I. Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis. PLoS medicine. 2022 Mar 22;19(3):e1003959.

• Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, Kassanjee R, Collie S, Sanne I, Boulle A, Seocharan I. Effectiveness of the Ad26. COV2. S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. The Lancet. 2022 Mar 19;399(10330):1141-53.

• Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, Amoako DG, Everatt J, Bhiman JN, Scheepers C, Tebeila N. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. The Lancet. 2022 Jan 29;399(10323):437-46.

• Davies MA, Kassanjee R, Rousseau P, Morden E, Johnson L, Solomon W, Hsiao NY, Hussey H, Meintjes G, Paleker M, Jacobs T. Outcomes of laboratory‐confirmed SARS‐CoV‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Tropical Medicine & International Health. 2022 Jun;27(6):564-73.

• Valley-Omar Z, Marais G, Iranzadeh A, Naidoo M, Korsman S, Maponga T, Hussey H, Davies MA, Boulle A, Doolabh D, Laubscher M. Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests. Journal of Virological Methods. 2022 Apr 1;302:114471.

• van der Hoven J, Allen E, Cois A, de Waal R, Maartens G, Myer L, Malaba T, Madlala H, Nyemba D, Phelanyane F, Boulle A. Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment. BMC Pregnancy and Childbirth. 2022 Dec;22(1):1-5.

• Kalk E, Heekes A, Slogrove AL, Phelanyane F, Davies MA, Myer L, Euvrard J, Kroon M, Petro G, Fieggen K, Stewart C. Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER). BMJ open. 2022 Jun 1;12(6):e060205.

• Cassidy T, Cornell M, Runeyi P, Dutyulwa T, Kilani C, Duran LT, Zokufa N, de Azevedo V, Boulle A, Horsburgh CR, Fox MP. Attrition from HIV care among youth initiating ART in youth‐only clinics compared with general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis. Journal of the International AIDS Society. 2022 Jan;25(1):e25854.

• Paleker M, Davies MA, Raubenheimer P, Naude J, Boulle A, Hussey H. Change in profile of COVID-19 deaths in Western Cape Province, South Africa, during the fourth wave. SAMJ: South African Medical Journal. 2022 Mar;112(3):0-.

• Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Jesson J, Crichton S, Quartagno M, Yotebieng M, Abrams EJ, Chokephaibulkit K, Le Coeur S, Aké‐Assi MH, Patel K, Pinto J. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. Journal of the International AIDS Society. 2022 Mar;25(3):e25871.

• Hussey H, Davies MA, Heekes A, Williamson C, Valley-Omar Z, Hardie D, Korsman S, Doolabh D, Preiser W, Maponga T, Iranzadeh A. Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections–a survival analysis. International Journal of Infectious Diseases. 2022 May 1;118:150-4.

• Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. The Lancet HIV. 2022 May 1;9(5):e353-62.

• Valley-Omar Z, Marais G, Iranzadeh A, Naidoo M, Korsman S, Maponga T, Hussey H, Davies MA, Boulle A, Doolabh D, Laubscher M. Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests. Journal of Virological Methods. 2022 Apr 1;302:114471.

• O'Bryant S, Petersen M, Hall J, Johnson L, Yaffe K, Braskie M, Toga AW, Rissman RA, HABLE study team. Characterizing plasma NfL in a community‐dwelling multi‐ethnic cohort: results from the HABLE study. Alzheimer's & Dementia. 2022 Feb;18(2):240-50.

• O'Bryant SE, Zhang F, Petersen M, Hall J, Johnson LA, Yaffe K, Braskie M, Rissman RA, Vig R, Toga AW, HABLE Study Team. Neurodegeneration from the AT (N) framework is different among Mexican Americans compared to non‐Hispanic Whites: a Health & Aging Brain among Latino Elders (HABLE) Study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2022;14(1):e12267.

• Nyemba DC, Peters RP, Medina-Marino A, Klausner JD, Ngwepe P, Myer L, Johnson LF, Joseph Davey DL. Impact of aetiological screening of sexually transmitted infections during pregnancy on pregnancy outcomes in South Africa. BMC Pregnancy and Childbirth. 2022 Mar 9;22(1):194.

• Nyemba DC, Kalk E, Vinikoor MJ, Madlala HP, Mubiana-Mbewe M, Mzumara M, Moore CB, Slogrove AL, Boulle A, Davies MA, Myer L. Growth patterns of infants with in-utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia. BMC Public Health. 2022 Dec;22:1-4.

• Joseph Davey DL, Dovel K, Mvududu R, Nyemba D, Mashele N, Bekker LG, Gorbach PM, Coates TJ, Myer L. Pre-exposure prophylaxis recent adherence with real-time adherence feedback and partner human immunodeficiency virus self-testing: a pilot trial among postpartum women. InOpen Forum Infectious Diseases 2022 Feb 1 (Vol. 9, No. 2, p. ofab609). US: Oxford University Press.

• Ford N, Patten G, Rangaraj A, Davies MA, Meintjes G, Ellman T. Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis. The Lancet HIV. 2022 Mar 1;9(3):e150-9.

• Nyakato P, Schomaker M, Fatti G, Tanser F, Euvrard J, Sipambo N, Fox MP, Haas AD, Yiannoutsos CT, Davies MA, Cornell M. Virologic non‐suppression and early loss to follow up among pregnant and non‐pregnant adolescents aged 15–19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study. Journal of the International AIDS Society. 2022 Jan;25(1):e25870.

• Justice AC, Goetz MB, Stewart CN, Hogan BC, Humes E, Luz PM, Castilho JL, Nash D, Brazier E, Musick B, Yiannoutsos C. Delayed presentation of HIV among older individuals: a growing problem. The Lancet HIV. 2022 Apr 1;9(4):e269-80.

• Hlongwa M, Cornell M, Malone S, Pitsillides P, Little K, Hasen N. Uptake and short-term retention in HIV treatment among men in South Africa: the coach mpilo pilot project. Global Health: Science and Practice. 2022 Feb 28;10(1).

• Davies C, Johnson L, Sawry S, Chimbetete C, Brian EL, Vinikoor M, Technau KG, Ehmer J, Rabie H, Phiri S, Tanser F. Effect of antiretroviral therapy care interruptions on mortality in children living with HIV: cohort study from Southern Africa. AIDS (London, England). 2022 Apr 4;36(5):729.

• Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, Kassanjee R, Collie S, Sanne I, Boulle A, Seocharan I. Effectiveness of the Ad26. COV2. S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. The Lancet. 2022 Mar 19;399(10330):1141-53.

• Kassanjee R, Welte A, Otwombe K, Jaffer M, Milovanovic M, Hlongwane K, Puren AJ, Hill N, Mbowane V, Dunkle K, Gray G. HIV incidence estimation among female sex workers in South Africa: a multiple methods analysis of cross-sectional survey data. The Lancet HIV. 2022 Nov 1;9(11):e781-90.

• Farrant L, Harding R, Anderson D, Greeff L, Kassanjee R, Krause R, Mohamed Z, Parkes J, Gwyther L. Symptom prevalence and burden, and the risk of depression among patients with advanced cancer attending two South African oncology units. ecancermedicalscience. 2022;16.

• Tlali M, Scheibe A, Ruffieux Y, Cornell M, Wettstein AE, Egger M, Davies MA, Maartens G, Johnson LF, Haas AD. Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: a cohort study. International journal of drug policy. 2022 Nov 1;109:103853.

• Medina-Marino A, Bezuidenhout D, Ngcelwane N, Cornell M, Wainberg M, Beyrer C, Bekker LG, Daniels J. Qualitative Identification of Intervention Preferences to Support Men’s Engagement and Retention in TB Care in South Africa. American journal of men's health. 2022 Oct;16(5):15579883221129349.

• Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome MJ, Amoako DG, Everatt J, Bhiman JN, Scheepers C, Tebeila N. Clinical severity of SARS-CoV-2 Omicron BA. 4 and BA. 5 lineages compared to BA. 1 and Delta in South Africa. Nature communications. 2022 Oct 4;13(1):5860.

• Tlali M, Scheibe A, Ruffieux Y, Cornell M, Wettstein AE, Egger M, Davies MA, Maartens G, Johnson LF, Haas AD. Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: a cohort study. International journal of drug policy. 2022 Nov 1;109:103853.

• Prinsloo M, Machisa M, Ward CL, Kassanjee R, Neethling I, Artz L, Jewkes R, Abrahams N, Pillay-van Wyk V, Matzopoulos R, Bradshaw D. Estimating the changing burden of disease attributable to interpersonal violence in South Africa for 2000, 2006 and 2012. South African Medical Journal. 2022 Oct 12;112(8b):693-704.

• Maskew M, Technau K, Davies MA, Vreeman R, Fox MP. Adolescent retention in HIV care within differentiated service-delivery models in sub-Saharan Africa. The Lancet HIV. 2022 Oct 1.

• Hussey H, Davies MA, Heekes A, Williamson C, Valley-Omar Z, Hardie D, Korsman S, Doolabh D, Preiser W, Maponga T, Iranzadeh A. Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study. Gates Open Research. 2022 Aug 31;6(117):117.

• Jamieson L, Johnson LF, Nichols BE, Delany-Moretlwe S, Hosseinipour MC, Russell C, Meyer-Rath G. Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis. The Lancet HIV. 2022 Dec 1;9(12):e857-67.

• Boily MC, Barnabas RV, Rönn MM, Bayer CJ, van Schalkwyk C, Soni N, Rao DW, Staadegaard L, Liu G, Silhol R, Brisson M. Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening. EClinicalMedicine. 2022 Dec 1;54.

• McCann NC, Stanic T, Penazzato M, Flanagan CF, Abrams EJ, Dugdale CM, Johnson LF, Neilan AM, Davies MA, Freedberg KA, Fassinou P. Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model‐based analysis to inform paediatric HIV screening programmes. Journal of the International AIDS Society. 2022 Dec;25(12):e26045.

• Brazier E, Ajeh R, Maruri F, et al. Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc 2022; 25: e26036. DOI: 10.1002/jia2.26036.
   
• Edmonds A, Brazier E, Musick BS, et al. Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med 2022; 19: e1004089. 20220915. DOI: 10.1371/journal.pmed.1004089.
   
• Hussey H, Vreede H, Davies MA, et al. Epidemiology and outcomes of SARS-CoV-2 infection associated with anti-nucleocapsid seropositivity in Cape Town, South Africa. medRxiv 2022 20221205. DOI: 10.1101/2022.12.01.22282927.
   
• Ismail M, Morden E, Hussey H, et al. Evaluation of a public COVID-19 dashboard in the Western Cape, South Africa: a tool for communication, trust, and transparency. BMC Public Health 2022; 22: 2453. 20221229. DOI: 10.1186/s12889-022-14657-w.
   
• Brito AF, Semenova E, Dudas G, et al. Global disparities in SARS-CoV-2 genomic surveillance. Nat Commun 2022; 13: 7003. 20221116. DOI: 10.1038/s41467-022-33713-y.
   
• Kubjane M, Osman M, Boulle A, et al. The impact of HIV and tuberculosis interventions on South African adult tuberculosis trends, 1990-2019: a mathematical modeling analysis. Int J Infect Dis 2022; 122: 811-819. 20220721. DOI: 10.1016/j.ijid.2022.07.047.
   
• Joseph Davey D, Nyemba DC, Castillo‐Mancilla J, Wiesner L, Norman J, Mvududu R, Mashele N, Johnson LF, Bekker LG, Gorbach P, Coates TJ. Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study. Journal of the International AIDS Society. 2022 Dec;25(12):e26044.
   
• Wada PY, Kim A, Jayathilake K, et al. Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000-2016. AIDS Patient Care STDS 2022; 36: 343-355. 20220826. DOI: 10.1089/apc.2022.0042.
   
• Nyakato P, Christ B, Anderegg N, et al. High Unreported Mortality in Children and Youth (<25 Years) Living With HIV Who Were Lost to Care From Antiretroviral Therapy Programs in Southern Africa: Results From a Multicountry Tracing Study. J Acquir Immune Defic Syndr 2022; 91: 429-433. 20220909. DOI: 10.1097/qai.0000000000003090.
   

2021

• Mouton JP, Jobanputra N, Njuguna C, Gunter H, Stewart A, Mehta U, Court R, Igumbor E, Maartens G, Cohen K. Adult medical emergency unit presentations due to adverse drug reactions in a setting of high HIV prevalence. African Journal of Emergency Medicine. 2021 Mar 1;11(1):46-52.
   
• Desmonde S, Ciaranello AL, Malateste K, Musick B, Patten G, Vu AT, Edmonds A, Neilan AM, Duda SN, Wools-Kaloustian K, Davies MA. Age-specific mortality rate ratios in adolescents and youth aged 10–24 years living with perinatally versus nonperinatally acquired HIV. AIDS (London, England). 2021 Mar 3;35(4):625.
   
• Bassett IV, Xu A, Giddy J, Bogart LM, Boulle A, Millham L, Losina E, Parker RA. Changing contextual factors from baseline to 9-months post-HIV diagnosis predict 5-year mortality in Durban, South Africa. AIDS care. 2021 Dec 2;33(12):1543-50.
   
• Amir Shroufi, Tom Chiller, Alex Jordan, David W Denning, Thomas S Harrison, Nelesh P Govender, Angela Loyse, Solange Baptiste, Radha Rajasingham, David R Boulware, Isabela Ribeiro, Joseph N Jarvis, Gilles Van Cutsem. Ending deaths from HIV-related cryptococcal meningitis by 2030. The Lancet Infectious Diseases. 2021 Jan 1;21(1):16-8.
   
• Hermans SM, Zinyakatira N, Caldwell J, Cobelens FG, Boulle A, Wood R. High rates of recurrent tuberculosis disease: a population-level cohort study. Clinical infectious diseases. 2021 Jun 1;72(11):1919-26.
   
• Nyemba DC, Medina-Marino A, Peters RP, Klausner JD, Ngwepe P, Myer L, Johnson LF, Davey DJ. Prevalence, incidence and associated risk factors of STIs during pregnancy in South Africa. Sexually transmitted infections. 2021 Aug 1;97(5):375-81.
   
• Mehta U, Smith M, Kalk E, Hayes H, Swart A, Tucker L, Coetzee R, Boulle A, Blockman M. Understanding and responding to prescribing patterns of sodium Valproate-Containing medicines in pregnant women and women of childbearing age in Western Cape, South Africa. Drug Safety. 2021 Jan;44:41-51.

 

2020

• Mendelsohn AS, De Sá A, Morden E, Botha B, Boulle A, Paleker M, Davies MA. COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce. South African Medical Journal. 2020;112(2):68-70.
   
• Osler M, Cornell M, Ford N, Hilderbrand K, Goemaere E, Boulle A. Population‐wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis. Journal of the International AIDS Society. 2020 Jun;23:e25530.
   
• Farley ES, Amirtharajah M, Winters RD, Taiwo AO, Oyemakinde MJ, Fotso A, Torhee LA, Mehta UC, Bil KA, Lenglet AD. Outcomes at 18 mo of 37 noma (cancrum oris) cases surgically treated at the Noma Children's Hospital, Sokoto, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2020 Nov;114(11):812-9.
   
• Springer PE, Slogrove AL, Kidd M, Kalk E, Bettinger JA, Esser MM, Cotton MF, Zunza M, Molteno CD, Kruger M. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2–3 years of age in Cape Town, South Africa. AIDS care. 2020 Apr 2;32(4):411-9.
   
• Gill K, Johnson L, Dietrich J, Myer L, Marcus R, Wallace M, Pidwell T, Mendel E, Fynn L, Jones K, Wiesner L. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial. The lancet child & adolescent health. 2020 Dec 1;4(12):875-83.
   
• Gill K, Happel AU, Pidwell T, Mendelsohn A, Duyver M, Johnson L, Meyer L, Slack C, Strode A, Mendel E, Fynn L. An open‐label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose). Journal of the International AIDS Society. 2020 Oct;23(10):e25626.
   
• Johnson LF, Kubjane M, Eaton JW. Challenges in estimating HIV prevalence trends and geographical variation in HIV prevalence using antenatal data: Insights from mathematical modelling. Plos one. 2020 Nov 20;15(11):e0242595.
   
• Tsondai PR, Braithewaite K, Fatti G, Bolton-Moore C, Chimbetete C, Rabie H, Phiri S, Sawry S, Eley B, Hobbins MA, Boulle A. Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa. AIDS (London, England). 2020 Dec 12;34(15):2275.
   
• Tsondai PR, Sohn AH, Phiri S, Sikombe K, Sawry S, Chimbetete C, Fatti G, Hobbins MA, Technau KG, Rabie H, Bernheimer J. Characterizing the double‐sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa. Journal of the International AIDS Society. 2020 Jan;23(1):e25447.
   
• Jacob N, Rice B, Kalk E, Heekes A, Morgan J, Brinkmann S, Hargreaves J, Orgill M, Boulle A. Consolidating strategic information to monitor progress against the UNAIDS 90–90–90 targets: evaluating the operational feasibility of an electronic HIV testing register in Cape Town, South Africa. BMC health services research. 2020 Dec;20:1-4.
   
• Sawry S, Patel F, Fairlie L, Balkus JE, Kalk E. COVID-19 in pregnancy in South Africa: tracking the epidemic and defining the natural history. South African Medical Journal. 2020 Aug 17;110(8):729-31.
   
• Iyun V, Technau KG, Eley B, Rabie H, Boulle A, Fatti G, Egger M, Tanser F, Wood R, Fairlie L, Cotton MF. Earlier antiretroviral therapy initiation and decreasing mortality among HIV-infected infants initiating antiretroviral therapy within 3 months of age in South Africa, 2006–2017. The Pediatric infectious disease journal. 2020 Feb;39(2):127.
   
• Johnson LF, Mutemaringa T, Heekes A, Boulle A. Effect of HIV infection and antiretroviral treatment on pregnancy rates in the Western Cape province of South Africa. The Journal of infectious diseases. 2020 Jun 11;221(12):1953-62.
   
• Leong TD, McGee SM, Gray AL, De Waal R, Kredo T, Cohen K, Reubenson G, Blockman M, Nel J, Maartens G, Rees H. Essential medicine selection during the COVID-19 pandemic: Enabling access in uncharted territory. SAMJ: South African Medical Journal. 2020 Oct;110(10):0-.
   
• Slogrove AL, Powis KM, Johnson LF, Stover J, Mahy M. Estimates of the global population of children who are HIV-exposed and uninfected, 2000–18: a modelling study. The Lancet Global Health. 2020 Jan 1;8(1):e67-75.
   
• Haas AD, Ruffieux Y, van den Heuvel LL, Lund C, Boulle A, Euvrard J, Orrell C, Prozesky HW, Tiffin N, Lovero KL, Tlali M. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records. The Lancet Global Health. 2020 Oct 1;8(10):e1326-34.
   
• Njau B, Lisasi E, Damian DJ, Mushi DL, Boulle A, Mathews C. Feasibility of an HIV self-testing intervention: a formative qualitative study among individuals, community leaders, and HIV testing experts in northern Tanzania. BMC Public Health. 2020 Dec;20(1):1-5.
   
• Ndlovu Z, Burton R, Stewart R, Bygrave H, Roberts T, Fajardo E, Mataka A, Szumilin E, Kerschberger B, Van Cutsem G, Ellman T. Framework for the implementation of advanced HIV disease diagnostics in sub-Saharan Africa: programmatic perspectives. The Lancet HIV. 2020 Jul 1;7(7):e514-20.
   
• Shroufi A, Van Cutsem G, Cambiano V, Bansi-Matharu L, Duncan K, Murphy RA, Maman D, Phillips A. HIV viral load algorithm: what are the needs in the field?: authors’ response. AIDS. 2020 Jan 1;34(1):160-2.
   
• Platt L, Xu A, Giddy J, Bogart LM, Boulle A, Parker RA, Losina E, Bassett IV. Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South Africa. PloS one. 2020 Sep 21;15(9):e0238975.
   
• Hauser A, Kusejko K, Johnson LF, Günthard HF, Riou J, Wandeler G, Egger M, Kouyos RD. Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study. PLoS medicine. 2020 Dec 14;17(12):e1003397.
   
• Mangana F, Massaquoi LD, Moudachirou R, Harrison R, Kaluangila T, Mucinya G, Ntabugi N, Van Cutsem G, Burton R, Isaakidis P. Impact of the implementation of new guidelines on the management of patients with HIV infection at an advanced HIV clinic in Kinshasa, Democratic Republic of Congo (DRC). BMC Infectious Diseases. 2020 Dec;20:1-9.
   
• Tymejczyk O, Brazier E, Wools-Kaloustian K, Davies MA, Dilorenzo M, Edmonds A, Vreeman R, Bolton C, Twizere C, Okoko N, Phiri S. Impact of universal antiretroviral treatment eligibility on rapid treatment initiation among young adolescents with human immunodeficiency virus in Sub-Saharan Africa. The Journal of infectious diseases. 2020 Aug 4;222(5):755-64.
   
• Chammartin F, Ostinelli CH, Anastos K, Jaquet A, Brazier E, Brown S, Dabis F, Davies MA, Duda SN, Malateste K, Nash D. International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012–2019. BMJ open. 2020 May 1;10(5):e035246.
   
• Farley E, Lenglet A, Abubakar A, Bil K, Fotso A, Oluyide B, Tirima S, Mehta U, Stringer B. Language and beliefs in relation to noma: a qualitative study, northwest Nigeria. PLoS Neglected Tropical Diseases. 2020 Jan 23;14(1):e0007972.
   
• Haas AD, Technau KG, Pahad S, Braithwaite K, Madzivhandila M, Sorour G, Sawry S, Maxwell N, von Groote P, Tlali M, Davies MA. Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa. Journal of the International AIDS Society. 2020 Dec;23(12):e25644.
   
• Esra RT, Johnson LF. Modelling the impact of screening for chlamydia and gonorrhoea in youth and other high-prevalence groups in a resource-limited setting. International journal of public health. 2020 May;65:413-23.
   
• Patten G, Puthanakit T, McGowan CC, Wools‐Kaloustian K, Hazra R, Pinto JA, Machado D, Succi R, Sohn AH, Rabie H, Musick B. Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium. Journal of the International AIDS Society. 2020 Jul;23(7):e25580.
   
• Pillay T, Cornell M, Fox MP, Euvrard J, Fatti G, Technau KG, Sipambo N, Prozesky H, Eley B, Tanser F, Johnson LF. Recording of HIV viral loads and viral suppression in South African patients receiving antiretroviral treatment: a multicentre cohort study. Antiviral therapy. 2020 Jul;25(5):257-66.
   
• Moudachirou R, Van Cutsem G, Chuy RI, Tweya H, Senkoro M, Mabhala M, Zolfo M. Retention and sustained viral suppression in HIV patients transferred to community refill centres in Kinshasa, DRC. Public Health Action. 2020 Mar 21;10(1):33-7.
   
• Kalk E, Heekes A, Mehta U, de Waal R, Jacob N, Cohen K, Myer L, Davies MA, Maartens G, Boulle A. Safety and effectiveness of isoniazid preventive therapy in pregnant women living with human immunodeficiency virus on antiretroviral therapy: an observational study using linked population data. Clinical Infectious Diseases. 2020 Oct 15;71(8):e351-8.
   
• Mouton JP, Fortuin-de Smidt MC, Jobanputra N, Mehta U, Stewart A, de Waal R, Technau KG, Argent A, Kroon M, Scott C, Cohen K. Serious adverse drug reactions at two children’s hospitals in South Africa. BMC pediatrics. 2020 Dec;20(1):1-4.
   
• Johnson LF, Patrick M, Stephen C, Patten G, Dorrington RE, Maskew M, Jamieson L, Davies MA. Steep declines in pediatric AIDS mortality in South Africa, despite poor progress towards pediatric diagnosis and treatment targets. The Pediatric infectious disease journal. 2020 Sep;39(9):843.
   
• Bell-Gorrod H, Fox MP, Boulle A, Prozesky H, Wood R, Tanser F, Davies MA, Schomaker M. The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on definition of failure time and CD4 count at failure. American Journal of Epidemiology. 2020 Aug 1;189(8):811-9.
   
• Jamieson L, Gomez GB, Rebe K, Brown B, Subedar H, Jenkins S, Shoko N, Bekker LG, Johnson LF, Meyer-Rath G. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa. Aids. 2020 May 1;34(6):883-91.
   
• Elise Farley, Modupe Juliana Oyemakinde, Jorien Schuurmans, Cono Ariti, Fatima Saleh, Gloria Uzoigwe, Karla Bil, Bukola Oluyide, Adolphe Fotso, Mohana Amirtharajah, Jorieke Vyncke, Raphael Brechard, Adeniyi Semiyu Adetunji, Koert Ritmeijer, Saskia van der Kam, Denise Baratti-Mayer, Ushma Mehta, Shafi'u Isah, Chikwe Ihekweazu, Annick Lenglet. The prevalence of noma in northwest Nigeria. BMJ global health. 2020 Apr 1;5(4):e002141.
   
• Amir Shroufi, Nelesh P Govender, Graeme Meintjes, John Black, Jeremy Nel, Mahomed-Yunus S Moosa, Colin Menezes, Halima Dawood, Douglas Wilson, Laura Trivino Duran, Olawale Ajose, Richard A Murphy, Thomas Harrison, Angela Loyse, Carol Ruffell, Gilles Van Cutsem Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme. International Journal of Infectious Diseases. 2020 Jun 1;95:459-61.
   
• Desmonde S, Neilan AM, Musick B, Patten G, Chokephaibulkit K, Edmonds A, Duda SN, Malateste K, Wools‐Kaloustian K, Ciaranello AL, Davies MA. Time‐varying age‐and CD4‐stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium. Journal of the International AIDS Society. 2020 Oct;23(10):e25617.
   
• Smith PJ, Oulo B, Wallace M, Gill K, Beijneveld JA, Bennie T, Myer L, Dietrich JJ, Johnson LF, Gray G, Bekker LG. Uptake and acceptability of medical male circumcision among young males in two culturally distinct settings in South Africa: A longitudinal, community-based study (the MACHO study). South African Medical Journal. 2020 Sep 30;110(10):1050-5.
   
• Jacob N, Rice B, Kalk E, Heekes A, Morgan J, Hargreaves J, Boulle A. Utility of digitising point of care HIV test results to accurately measure, and improve performance towards, the UNAIDS 90-90-90 targets. PLoS One. 2020 Jun 30;15(6):e0235471.
   
• Nyakato P, Davies MA, Technau KG, Fatti G, Rabie H, Tanser F, Boulle A, Wood R, Eley B, Sawry S, Giddy J. Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission. Plos one. 2020 May 29;15(5):e0233693.
   
• Jesson J, Desmonde S, Yiannoutsos CT, Patten G, Malateste K, Duda SN, Kumarasamy N, Yotebieng M, Davies MA, Musick B, Leroy V. Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Research Notes. 2020 Dec;13(1):1-6.
   
• Zaniewski E, Dao Ostinelli CH, Chammartin F, Maxwell N, Davies MA, Euvrard J, van Dijk J, Bosomprah S, Phiri S, Tanser F, Sipambo N. Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa. Journal of the International AIDS Society. 2020 Jul;23(7):e25546.

 

2019

• de Beer, S.,  Kalk, E.,  Kroon, M.,  Boulle, A.,  Osler, M.,  Euvrard, J.,  Timmerman, V. and  Davies, M.-A.  A longitudinal analysis of the completeness of maternal HIV testing, including repeat testing in Cape Town, South Africa. J Intern AIDS Soc.  2019;  23(1):e25441
   
• Elise Farley, Hussaina Muhammad Bala, Annick Lenglet, Ushma Mehta, Nura Abubakar, Joseph Samuel, Annette de Jong, Karla Bil, Bukola Oluyide, Adolphe Fotso, Beverley Stringer, Julita Gil Cuesta and Emilie Venables.  I treat it but I don’t know what this disease is’: A qualitative study on noma (cancrum oris) and traditional healing in northwest Nigeria. International Health 2019, 12(1); 28-35.
   
• Joseph Daniels, Helen Struthers, Kabelo Maleke, Tim Lane, James McIntyre, Tom Coates. ‘My Tablets are on Top of the Fridge’: The Roles of Relationship Desire and Medical Mistrust in ART Adherence for HIV-Positive MSM and Transgender Women Living in Rural South Africa. Aids and Behaviour 2019, 23; 2849-2858.
   
• Avy Violari, Mark F. Cotton, Louise Kuhn, Diana B. Schramm, Maria Paximadis, Shayne Loubser, Sharon Shalekoff, Bianca Da Costa Dias, Kennedy Otwombe, Afaaf Liberty, James McIntyre, Abdel Babiker, Diana Gibb & Caroline T. Tiemessen. A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation. Nature Communications 2019, 10:412.
   
• Victoria Nembaware, Katherine Johnston, Alpha A. Diallo, Maritha J. Kotze, Alice Matimba, Keymanthri Moodley, Godfrey. B. Tangwa, Rispah Torrorey-Sawe and Nicky Tiffin.  A framework for tiered informed consent for health genomic research in Africa.  Nature Genetics 2019, 5; 1566-1571.
   
• Bernard Njau, Christopher Colvin, Esther Lisasi, Damian Damian, Declare Mushi, Andrew Boulle and Catherine Mathews. A systematic review of qualitative evidence on factors enabling and deterring uptake of HIV self-testing in Africa. BMC Public Health 2019, 19, Article 1289.
   
• Zara Shrubber, Nathan Ford. Adherence to HIV post-exposure prophylaxis for children/adolescents who have been sexually assaulted: A systematic review of barriers, enablers, and interventions. Child Abuse and Neglect 2019, Article 104143.
   
• Van Schalkwyk C., Moodley J., Welte A. and Johnson L.F. Are associations between HIV and human papillomavirus transmission due to behavioural confounding or biological effects? Sexually Transmitted Infections 2019, 9(2); 122-128.
   
• Ingrid V. Bassett, Ai Xu, Janet Giddy, Laura M. Bogart, Andrew Boulle, Lucia Millham, Elena Losina and Robert A. Parker. Assessing rates and contextual predictors of 5-year mortality among HIV-infected and HIV-uninfected individuals following HIV testing in Durban, South Africa. BMC Infectious Diseases 2019, 19, Article 751.
   
• Rivka R. Lilian, Kate Rees, Moyahabo Mabitsi, James A. McIntyre, Helen E. Struthers, Remco P.H. Peters. Baseline CD4 and mortality trends in the South African human immunodeficiency virus programme: Analysis of routine data. Southern African Journal of HIV Medicine 2019, 20(1).
   
• Ushma C. Mehta, Cari van Schalkwyk, Prineetha Naidoo, Arthi Ramkissoon, Otty Mhlongo, Niren R. Maharaj, Niree Naidoo, Karen Fieggen, Michael F. Urban, Shaun Krog, Alex Welte, Mukesh Dheda, Yogan Pillay, Neil F. Moran. Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa. Southern African Journal of HIV Medicine 2019, 20(1). 
   
• Hauser A., Kusejko K., Johnson L.F., Wandeler G., Riou J., Goldstein F., Egger M. and Kouyos R. Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa. PLoS Computational Biology 2019, 15(6).
   
• Olga Tymejczyk, Ellen Brazier, Constantin T. Yiannoutsos, Michael Vinikoor, Monique van Lettow, Fred Nalugoda, Mark Urassa, Jean d’Amour Sinayobye, Peter F. Rebeiro, Kara Wools-Kaloustian, Mary-Ann Davies, Elizabeth Zaniewski, Nanina Anderegg. Changes in rapid HIV treatment initiation after national “treat all” policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis. PLoS Medicine 2019, 16(6); 1-16.
   
• Charlotte M. Hoffman, Lise Fritz, Nthabiseng Matlakala, Nontembeko Mbambazela, Jean P. Railton, James A. McIntyre, Jan Henk Dubbink and Remco P. H. Peters. Community-based strategies to identify the unmet need for care of individuals with sexually transmitted infection-associated symptoms in rural South Africa. Tropical Medicine and International Health 2019, 24(8); 987-9931.
   
• Johanna M. E. Venter, Precious M. Mahlangu, Etienne E. Müller, David A. Lewis, Kevin Rebe, Helen Struthers, James McIntyre and Ranmini S. Kularatne. Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens. BMC Infectious Diseases 2019, 19; Article 6.
   
• Lesosky Maia, Raboud Janet, Glass Tracy, Brummel Sean, Ciaranello Andrea, Currier Judith, Essajee Shaffiq, Havlir Diane, Koss Catherine, Ogwu Anthony, Shapiro Roger, Abrams Elaine, Myer Landon. Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa. Aidsonline 2019, 34(2); 311-315.
   
• Susan L Norris, Eva A Rehfuess, Helen Smith, Özge Tunçalp, Jeremy M Grimshaw, Nathan P Ford, Anayda Portela. Complex health interventions in complex systems: improving the process and methods for evidence-informed health decisions. BMJ Global Health 2019, 4(Supplement 1).
   
• Marco Vitoria, Ajay Rangaraj, Nathan Ford, and Meg Doherty. Current and future priorities for the development of optimal HIV drugs. Current Opinion in HIV and AIDS 2019, 14(2);143-149.
   
• Boulle A, Heekes A, Tiffin N, Smith M, Mutemaringa T, Zinyakatira N, Phelanyane F, Pienaar C, Buddiga K, Coetzee E, van Rooyen R, Dyers R, Fredericks N, Loff A, Shand L Moodley M, de Vega I and Vallabhjee K. Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa.         International Jounrnal of Population Data Science 2019, 4(2).
   
• Bernhard Kerschberger, Michael Schomaker, Alex Telnov, Debrah Vambe, Nicholas Kisyeri, Welile Sikhondze, Lorraine Pasipamire, Siphiwe Mavis Ngwenya, Barbara Rusch, Iza Ciglenecki and Andrew Boulle. Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: A cohort and population-based analysis. Tropical Medicine and International Health 2019, 24(9); 1114-1127.
   
• Kathrin Zurcher, Marie Ballif, Sasisopin Kiertiburanakul, Henri Chenal, Marcel Yotebieng, Beatriz Grinsztejn, Denna Michael, Timothy R Sterling, Kapella M Ngonyani, Anna M Mandalakas, Matthias Egger, April C Pettit, and Lukas Fenner for the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. Journal of the International AIDS Society 2019, 22(9).
   
• Menard L. Chihana, Helena Huerga, Gilles Van Cutsem, Tom Ellman, Eric Goemaere, Stephen Wanjala, Charlie Masiku, Elisabeth Szumilin, Jean-Francois Etard, David Maman & Mary-Ann Davies. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: A secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi). Global Health Action 2019, 12(1).
   
• Sally Hargreaves, Keiran Rustage, Laura B. Nellums, Joshua E. Bardfield, Bruce Agins, Pierre Barker, M. Rashad Massoud, Nathan P. Ford, Meg Doherty Gillian Dougherty and Satvinder Singh. Do Quality Improvement Initiatives Improve Outcomes for Patients in Antiretroviral Programs in Low- and Middle-Income Countries? A Systematic Review. Journal of AIDS 2019, 81(5); 487- 496.
   
• Iyun Victoria, Technau Karl-Gunter, Eley Brian FC, Rabie Helena, Boulle Andrew, Fatti Geoffrey, Egger Matthias, Tanser Frank, Wood Robin, Fairlie Lee, Cotton;Mark F., Davies Mary-Ann. Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-Infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006–2017. The Pediatric Infectious Disease Journal 2019, 39(2); 127-133. 
   
• Leigh F. Johnson, Themba Mutemaringa, Alexa Heekes and Andrew Boulle. Effect of HIV Infection and Antiretroviral Treatment on Pregnancy Rates in the Western Cape Province of South Africa. Journal of Infectious Diseases 2019.
   
• Van Schalkwyk C., Moodley J., Welte A. and Johnson L.F. Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions. Vaccine 2019, 37(36); 5460-5465. 
   
• Haas A.D., Johnson L.F., Grimsrud A., Ford N., Mugglin C., Fox M.P., Euvrard J., van Lettow, M., Prozesky H., Sikazwe I., Chimbetete C., Hobbins M., Kunzekwenyika C. and Egger M. Extending visit intervals for clinically stable patients on antiretroviral therapy: multicohort analysis of HIV programs in Southern Africa. Journal of Acquired Immune Deficiency Syndromes 2019, 81(4); 439-447.
   
• Bernhard Kerschberger, Kiran Jobanputra, Michael Schomaker, Serge M Kabore, Roger Teck, Edwin Mabhena, Nomthandazo Lukhele, Barbara Rusch, Andrew Boulle and Iza Ciglenecki. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: A prospective cohort study from Eswatini. Journal of IAS 2019, 22(10).
   
• Daniel P. O’Brien, Nathan Ford, Amadou G. Djirmay, Alexandra Calmy, Marco Vitoria, Tomas O. Jensen and Vanessa Christinet. Female Genital Schistosomiasis and HIV: Research Urgently Needed to Improve Understanding of the Health Impacts of This Important Coinfection. JAIDS 2019, 80(5); 489-493.   
   
• Johnson Leigh, Anderegg Nanina, Zaniewski Elizabeth, Eaton Jeffrey W, Rebeiro Peter, Carriquiry Gabriela, Nash Denis, Yotebieng Marcel, Ekouevi Didier, Holmes Charles, Choi Jun, Jiamsakul Awachana, Bakoyannis Giorgos, Althoff Keri, Sohn Annette Yiannoutsos Constantin, Egger, Matthias. Global variations in mortality in adults after initiating antiretroviral treatment- an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration.  Aidsonline 2019, 33;283-294.
   
• Geneviève A.F.S. van Liere, Marleen M. Kock,Oscar Radebe, Helen E. Struthers, Servaas Morre, James A. McIntyre and Remco P.H. Peters. High Rate of Repeat Sexually Transmitted Diseases Among Men Who Have Sex with Men in South Africa: A Prospective Cohort Study. Sexually Transmitted Disease 2019, 46(11); e105 -107.
   
• O Radebe, S A Lippman, T Lane, H Gilmore, E Agnew, A Manyuchi and J A McIntyre. HIV self-screening distribution preferences and experiences among men who have sex with men in Mpumalanga Province: Informing policy for South Africa. SAMJ 2019, 109(4); 
   
• Nathan Ford, Catherine Orrell, Zara Shubber, Tsitsi Apollo and Lara Vojnov.  HIV viral resuppression following an elevated viral load: A systematic review and meta-analysis. Journal of IAS 2019, 22(11).
   
• Euvrard, J., Schulz, T., Hilderbrand, K., Bosland, M., Osler, M., Boulle, A. and Davies, M.A. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa? South African Medical Journal 2019, 109(3);174-177.
   
• Nicki Tiffin, Asha George, Amnesty Elizabeth LeFevre. How to use relevant data for maximal benefit with minimal risk: Digital health data governance to protect vulnerable populations in low-income and middle-income countries. BMJ Global Health 2019, 4(2).
   
• Kabelo Maleke, Joseph Daniels, Tim Lane, Helen Struthers, James McIntyre and Thomas Coates.  How social stigma sustains the HIV treatment gap for MSM in Mpumalanga, South Africa. Global Health Promotion 2019, 26(4); 6-13). 
   
• lga Tymejczyk, Ellen Brazier, Kara Wools-Kaloustian, Mary-Ann Davies, Madeline Dilorenzo, Andrew Edmonds, Rachel Vreeman, Carolyn Bolton, Christella Twizere, Nicollate Okoko, Sam Phiri, Gertrude. Lelo, Per von Groote, Annette H Sohn and Dennis Nash on behalf of IeDEA Consortium. Impact of Universal Antiretroviral Treatment Eligibility on Rapid Treatment Initiation Among Young Adolescents with Human Immunodeficiency Virus in Sub-Saharan Africa. Journal of Infectious Diseases 2019, jiz547.
   
• Ellen Brazier, Fernanda Maruri, Stephany N Duda, Olga Tymejczyk, C William Wester, Geoffrey Somi, Jeremy Ross, Aimee Freeman, Morna Cornell, Armel Poda, Beverly S Musick, Fujie Zhang, Keri N Althoff, Catrina Mugglin, April D Kimmel, Marcel Yotebieng and Denis Nash for the IeDEA Consortium. Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. Journal of IAS 2019, 22(7).
   
• Jennifer Pellowski, Catherine Wedderburn, Jacob A M Stadler, Whitney Barnett, Dan Stein, Landon Myer and Heather J Zar. Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape. BMJ Open 2019, 9(12).
   
• Ying Zhao, Tamaryn Fox, Kathryn Manning, Annemie Stewart, Nicki Tiffin, Ntokozo Khomo, Joshua Leslie, Andrew Boulle, Vanessa Mudaly, Yulene Kock, Graeme Meintjies, Sean Wasserman. Improved Treatment Outcomes with Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study. Clinical Infectious Diseases 2019, 68(9);1522-1529.  
   
• Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, The Lancet HIV 2019, 6(2);105-115.
   
• Eduard Grebe, Shelley N. Facente, Jeremy Bingham, Christopher D. Pilcher, Andrew Powrie, Jarryd Gerber, Gareth Priede, Trust Chibawara, Michael P. Busch, Gary Murphy, Reshma Kassanjee, Alex Welte and on behalf of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online tool. BMC Infectious Diseases 2019, 19; Article 894.
   
• Asha George, Amnesty Elizabeth LeFevre, Tanya Jacobs, Mary Kinney, Kent Buse, Mickey Chopra, Bernadette Daelman, Anie Luis Huicho, Rajat Khosla, Kumanan Rasanathan, David Neha S Singh, Nicki Tiffin, Rajani Ved, Shehla Abbas Zaidi, Helen Schneider. Lenses and levels: the why, what and how of measuring health system drivers of women’s, children’s and adolescents’ health with a governance focus. BMJ Global Health 2019, 4(Supplement 4).
   
• Boltz VF, Shao W, Bale MJ, Halvas EK, Luke B, McIntyre JA, Schooley RT, Lockman S, Currier JS, Sawe F, Hogg E, Hughes MD, Kearney MF, Coffin JM, Mellors JW. Linked dual-class HIV resistance mutations are associated with treatment failure. JCI Insight 2019, 4(19).
   
• Samantha Kaplan, Katleho S. Nteso, Nathan Ford, Andrew Boulle, Graeme Meintjes. Loss to follow-up from antiretroviral therapy clinics: A systematic review and meta-analysis of published studies in South Africa from 2011 to 2015. SA Journal of HIV Medicine 2019, 20(1).
   
• Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS, IMPAACT PROMISE 1077BF/FF team. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: Results of a treatment strategy trial. HIV Clinical Trials, 19(6); 209-224.
   
• Joseph Davey D., Bekker L.G., Gomba Y., Coates T., Myer L. and Johnson L.F.Modelling the potential impact of providing pre-exposure prophylaxis (PrEP) to pregnant and breastfeeding women in South Africa. AIDS 2019, 33(8);1391-1395.
   
• Maheu-Giroux, Marsh, Doyle CM, Godin A, Lanièce Delaunay C, Johnson LF, Jahn A, Abo K, Mbofana F, Boily MC, Buckeridge DL, Hankins CA, Eaton JW. National HIV testing and diagnosis coverage in sub-Saharan Africa: A new modeling tool for estimating the 'first 90' from program and survey data. AIDS 2019, 33 (Supplement 3); s255-S269.
   
• Johnson L.F., van Rensburg C., Govathson C. and Meyer-Rath G. Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness. Scientific Reports 2019, 9(1).
   
• Lynne M Mofenson, Anton L Pozniak, Jacque Wambui, Elliot Raizes, Andrea Ciaranello, Polly Clayden, Peter Ehrenkranz, Ade Fakoya, Andrew Hill, Saye Khoo, Imelda Mahaka, Surbhi Modi, Cynthia Moore, Andrew Phillips, George Siberry, Kenly Sikwese, Claire Thorne, Heather D Watts, Meg Doherty and Nathan P Ford. Optimizing responses to drug safety signals in pregnancy: The example of dolutegravir and neural tube defects. Journal of IAS 2019, 22(7).
   
• Joseph Sharp, Lynne Wilkinson, Vivian Cox, Carol Cragg, Gilles van Cutsem, Anna Grimsrud. Outcomes of patients enrolled in an antiretroviral adherence club with recent viral suppression after experiencing elevated viral loads.  South African Journal of HIV Medicine 2019, 20(1).
   
• Catherine L. Ward, Inge M. Wessels, Jamie M. Lachman, Judy Hutchings, Lucie D. Cluver, Reshma Kassanjee, Raymond Nhapi, Francesca Little, and Frances Gardner. Parenting for Lifelong Health for young children: A randomized controlled trial of a parenting program in South Africa to prevent harsh parenting and child conduct problems. Journal of Child Psychology and Psychiatry 2019.
   
• Damian Hacking, Zodwa Mgengwana-Mbakaza, Tali Cassidy, Pumeza Runeyi, Laura Trivino Duran, Ruth Henwood Mathys and Andrew Boulle. Peer Mentorship via Mobile Phones for Newly Diagnosed HIV-Positive Youths in Clinic Care in Khayelitsha, South Africa: Mixed Methods Study. JMIR 2019, 21(12).
   
• Lara Vojnov, Miriam Taegtmeyer, Caroline Boeke, Jessica Markby, Lindsay Harris, Meg Doherty, Trevor Peter, Nathan Ford. Performance of non-laboratory staff for diagnostic testing and specimen collection in HIV programs: A systematic review and meta-analysis. PLOS One 2019.
   
• Slogrove A.L., Johnson L.F. and Powis. Population-level mortality associated with HIV exposure in HIV-uninfected infants in Botswana and South Africa: A model-based evaluation. Journal of Tropical Pediatrics 2019, 65(4); 373-379.
   
• Andrew Phillips, Valentina Cambiano, Leigh Johnson, Fumiyo Nakagawa, Rick Homan, Gesine Meyer-Rath, Thomas Rehle, Frank Tanser, Sizulu Moyo, Maryam Shahmanesh, Delivette Castor, Elizabeth Russell, Lise Jamieson, Loveleen Bansi-Matharu, Amir Shroufi, Ruanne Barnabas, Urvi M Parikh, John W Mellors and Paul Revill. Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance. Journal of Infectious Diseases 2019.
   
• Nicki Tiffin. Potential risks and solutions for sharing genome summary data from African populations. BMC Medical Genomics 2019, 12( Article 152).
   
• Bernhard Kerschberger, Michael Schomaker, Iza Ciglenecki, Lorraine Pasipamire, Edwin Mabhena, Alex Telnov, Barbara Rusch, Nomthandazo Lukhele, Roger Teck and Andrew Boulle. Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat-all approach in rural Eswatini. Tropical Medicine and International Health 2019, 24(6); 701-714.
   
• Emily A. Kendall, Andrew S. Azman, Gary Maartens, Andrew Boulle, Robert J. Wilkinson, David W. Dowdy and Molebogeng X. Rangaka. Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting. AIDS 2019, 33(3); 525-536.
   
• Charlotte M. Hoffman, Nontembeko Mbambazela, Phumzile Sithole, Servaas A. Morré, Jan Henk Dubbink, Jean Railton, James A. McIntyre, Marleen M. Kock, and Remco P.H. Peters. Provision of Sexually Transmitted Infection Services in a Mobile Clinic Reveals High Unmet Need in Remote Areas of South Africa: A Cross-sectional Study. Sexually Transmitted Disease 2019, 46(3); 206-212.
   
• N. Naidoo, N. Matlakala, J. Railton, S. Khosa, G. Marincowitz, J. O. Igumbor, J. A. McIntyre, H. E. Struthers and R. P. H. Peters. Provision of HIV services by community health workers should be strengthened to achieve full programme potential: A cross-sectional analysis in rural South Africa.  Tropical Medicine and International Health 2019, 24(4); 401-408.
   
• Mark N. Lurie, Kipruto Kirwa, Julia Callaway, Morna Cornell, Andrew Boulle, Angela M. Bengtson, Mariette Smith, Natalie Leon and Christopher Colvin. Quantifying the HIV treatment cascade in a South African health sub-district by gender: Retrospective cohort study. Tropical Medicine and International Health 2019.
   
• Sarah Jane Steele, Hartini Sugianto, Quentin Baglione, Sandra Sedlimaier, Aline Aurore Niyibizi, Kristal Duncan, Julia Hill, Jesper Brix, Mit Philips, Gilles Van Cutsem and Amir Shroufi. Removal of user fees and system strengthening improves access to maternity care, reducing neonatal mortality in a district hospital in Lesotho. Tropical Medicine and International Health 2019, 24(1); 2-10.
   
• Bock P, Nel K, Fatti G, Sloot R, Jennings K, Voget J, Gunst C, Farmer N, Cloete R, Grobbelaar N, Louis F, Floyd S, Hayes R, Ayles H, Beyers N, Fidler S on behalf of the HPTN 071 (PopART) team. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa. HIV Med 2019, 20(6).
   
• Marcel Yotebieng, Ellen Brazier, Diane Addison, April D Kimmel, Morna Cornell, Olivia Keiser, Angela M Parcesepe, Amobi Onovo, Kathryn E Lancaster, Barbara Castelnuovo, Pamela M Murnane, Craig R Cohen, Rachel C Vreeman, Mary-Ann Davies, Stephany N Duda, Constantin T Yiannoutsos, Rose S Bono, Robert Agler, Charlotte Bernard, Jennifer L Syvertsen, Jean d’Amour Sinayobye, Radhika Wikramanayake, Annette H Sohn, Per M von Groote, Gilles Wandeler, Valeriane Leroy, Carolyn F Williams, Kara Wools-Kaloustian, Denis Nash and for the IeDEA Treat All in sub-Saharan Africa Consensus Statement Working Group. Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). Journal of IAS 2019, 22(1); 1-16.
   
• Peter Bock, Colette Gunst, Leonard Maschilla, Rory Holtman, Nelis Grobbelaar, Dillon Wademan, Rory Dunbar, Geoffrey Fatti, James Kruger, Nathan Ford, Graeme Hoddinott and Sue-Ann Meehan. Retention in care and factors critical for effectively implementing antiretroviral adherence clubs in a rural district in South Africa. Journal of IAS 2019, 22(10).
   
• Sabin Nsanzimana, Muhammed Semakula, Vedaste Ndahindwa, Eric Remera, Dieudonne Sebuhoro, Jean Paul Uwizihiwe, Nathan Ford, Marcel Tanner, Steve Kanters, Edward J. Mills and Heiner C. Bucher. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study. BMC Infectious Diseases 2019, 19(Article 312).
   
• Dorothy Sebikari, Mona Farhad, Terry Fenton, Maxensia Owor, Jeffrey S. A. Stringer, Min Qin, Nahida Chakhtoura, Benjamin H. Chi, Friday Saidi, Neetal Nevrekar, Avy Violari, Tsungai Chipato, James A. McIntyre, Dhayendre Moodley,Taha E. Taha, Gerhard Theron and Mary Glenn Fowler. Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial. JAIDS 2019, 81(5); 521-532.
   
• Joseph Daniels, Helen Struthers, Kabelo Maleke, Christina Catabay, Tim Lane, James McIntyre & Tom Coates. Rural school experiences of South African gay and transgender youth. Journal of LGBT Youth 2019, 16(4); 355-379.
   
• Catriona Waitt, Catherine Orrell, Stephen Walimbwa, Yashna Singh, Kenneth Kintu, Bryony Simmons, Julian Kaboggoza, Mary Sihlangu, JulieAnne Coombs, Thoko Malaba, Josaphat Byamugisha, Alieu Amara, Joshua Gini, Laura Else, Christie Heiburg, Eva Maria Hodel, Helen Reynolds, Ushma Mehta, Pauline Byakika-Kibwika, Andrew Hill, Landon Myer, Mohammed Lamorde, Saye Khoo. Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study). PLoS Medicine 2019, 16(9).
   
• P. Govender, Graeme Meintjes, Phetho Mangena, Jeremy Nel, Samantha Potgieter, Denasha Reddy, Helena Rabie, Douglas Wilson, John Black, David Boulware, Tom Boyles, Tom Chiller, Halima Dawood, Sipho Dlamini, Thomas S. Harrison, Prudence Ive, Joseph Jarvis, Alan Karstaedt, Matamela C. Madua, Colin Menezes, Mahomed-Yunus S. Moosa, Zaaheera Motlekar, Amir Shroufi, Sarah Lynn Stacey, Merika Tsitsi, Gilles van Cutsem, Ebrahim Variava, Michelle Venter, Rachel Wake. Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update. South African Journal of HIV Medicine 2019, 20(1).
   
• Bella Hwang, Amir Shroufi, Tinne Gils , Sarah Jane Steele, Anna Grimsrud, Andrew Boulle, Anele Yawa, Sasha Stevenson, Lauren Jankelowitz, Marije Versteeg Mojanaga, Indira Govender, John Stephens, Julia Hill, Kristal Duncan, Gilles van Cutsem. Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey. PLOS One 2019, 14(3).
   
• Rebe Kevin, Hoosen Nikhat, McIntyre James A. Strategies to improve access for MSM in low-income and middle-income countries.  Current Opinion in HIV and AIDS 2019, 14(5); 387-392.
   
• Julie Jesson, Michael Schomaker, Karen Malasteste, Dewi K Wati, Azar Kariminia, Mariam Sylla, Kouakou Kouadio, Shobna Sawry, Mwangelwa Mubiana-Mbewe, Samuel Ayaya, Rachel Vreeman, Catherine C McGowan, Marcel Yotebieng, Valeriane Leroy and Mary-Ann Davies on behalf of the IeDEA global cohort consortium. Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. Journal of IAS 2019, 22(11).
   
• Kelsey K. Case, Leigh F. Johnson, Mary Mahy, Kimberly Marsh, Virginie Supervie and Jeffrey W. Eaton. Summarizing the results and methods of the 2019 Joint United Nations Programme on HIV/AIDS HIV estimates. AIDSonline 2019, 33; 197-201.
   
• Geoffrey Jobson, Moyahabo Mabitsi, Jean Railton, Cornelis J. Grobbelaar, James A. McIntyre, Helen E. Struthers, Remco P.H. Peters. Targeted mentoring for human immunodeficiency virus programme support in South Africa. Southern African Journal of HIV Medicine 2019, 20(1).
   
• David C. Boettiger, Matthew G. Law, Annette H. Sohn, Mary-Ann Davies, Kara Wools-Kaloustian, Valeriane Leroy, Marcel Yotebieng, Michael Vinikoor, Rachel Vreeman, Madeleine Amorissani-Folquet, Andrew Edmonds, Geoffrey Fatti, James Batte, Lorna Renner, Aebola Adedimeji, and Azar Kariminia on behalf of the International Epidemiology Databases to Evaluate AIDS. Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency. Journal of Paediatric Infectious Diseases Soceity 2019, 8(5); 450-460.
   
• Rice B, Boulle A, Schwarcz S, Shroufi A, Rutherford G, Hargreaves J. The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance. JMIR Public Health 2019, 5(1).
   
• Sabine Hermans; Morna Cornell; Keren Middelkoop and Robin Wood. The differential impact of HIV and antiretroviral therapy on gender-specific tuberculosis rates. Tropical Medicine and International Health 2019, 24(4); 454-462.
   
• Johnson L.F., Mutemaringa T., Heekes A. and Boulle A. The effect of HIV infection and antiretroviral treatment on pregnancy rates in the Western Cape province of South Africa. Journal of Infectious Diseases 2019, jiz362.
   
• Nicola Wearne, Charles R. Swanepoel, Maureen S. Duffield, Bianca J. Davidson, Kathryn Manning, Nicki Tiffin, Andrew Boulle, Brian L. Rayner, Priyanka Naidu and Ikechi G. Okpechi. The effects of add-on corticosteroids on renal outcomes in patients with biopsy proven HIV associated nephropathy: a single centre study from South Africa. BMC Nephrology 2019, 20 (Article 44).
   
• Sarah Jane Steele, Naeemah Abrahams, Kristal Duncan, Nataly Woollett, Bella Hwang, Lucy O’Connell, Gilles van Cutsem, Amir Shroufi. The epidemiology of rape and sexual violence in the platinum mining district of Rustenburg, South Africa: Prevalence, and factors associated with sexual violence. PLOS ONE 2019, 14(7).
   
• A Myburgh, R Kassanjee, PR Pretorius. The influence of delayed sample processing time on PO2 values in critically ill patients with sepsis-induced leucocytosis. Southern African Journal of Anaesthesia and Analgesia 2019, 25(6); 21-25.  
                   
• Makhakhe N, Meyer-Weitz A, Struthers H, McIntyre J. The role of health and advocacy organisations in assisting female sex workers to gain access to health care in South Africa. BMC Health Services Research 2019, 19 (Article 746).
   
• Porgo T.V., Norris S.L., Salanti G., Johnson L.F., Simpson J.A., Low N., Egger M. and Althaus C.L.The use of mathematical modelling studies for evidence synthesis and guideline development: a glossary. Research Synthesis Methods 2019, 10(1); 125-133.
   
• Catherine Le, Paula Britto, Sean Brummel, Risa Hoffman, Jonathan Li, Patricia Flynn, Taha Taha, Anne Coletti, Mary Fowler, Ronald Bosch, Rajesh Gandhi, Karin Klingman, James McIntyre, Judith Currier. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men.  AIDS 2019, 33(14); 2149-2156.
   
• Malango T. Msukwa, Olivia Keiser, Andreas Jahn, Joep J. van Oosterhout, Andrew Edmonds, Nozgechi Phiri, Ronald Manjomo, Mary-Ann Davies and Janne Estill. Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV-infected pregnant women in Malawi. Tropical Medicine and International Health 2019, 24(6);727-735.
   
• Vincent Wong, Erin Jenkins, Nathan Ford and Heather Ingold. To thine own test be true: HIV self-testing and the global reach for the undiagnosed. JIAS 2019, 22( S1).
   
• K Anderson, R Muloiwa, M-A Davies. Treatment outcomes in perinatally infected HIV-positive adolescents and young adults after ≥10 years on antiretroviral therapy. South African Medical Journal 2019, 109(1); 27-34.
   
• Damian J. Damian, Bernard Njau, Ester Lisasi, Sia E. Msuya and Andrew Boulle. Trends in maternal and neonatal mortality in South Africa: A systematic review. Systematic Reviews 2019, 8 (Article 76).
   
• Stover John, Glaubius Robert, Morenson Lynne, Dugdale Caitlin M, Davies Mary-Ann, Patten Gabriela, Yiannoutsos Constantin. Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. Aidsonline 2019, 33; 227-234.
   
• Diwakar Mohan, Jean Juste Harrisson Bashinwa, Pierre Dane, Sara Chamberlain, Nicki Tiffin, Amnesty Lefevre. Use of Big Data and Machine Learning Methods in the Monitoring and Evaluation of Digital Health Programs in India: An Exploratory Protocol. JMIR 2019, 8(5).
   
• M. Schomaker, M.A. Luque-Fernandez, V. Leroy and M.A. Davies. Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions. Statistics in Medicine 2019, 38(24); 4888-4911.
   
• Gabriela Patten, Michael Schomaker,  Mary-Ann Davies, Helena Rabie, Gert van Zyl, Karl Technau, Brian Eley, Andrew Boulle, Russell B. Van Dyke, Kunjal Patel, Nosisa Sipambo, Robin Wood, Frank Tanser, Janet Giddy, Mark Cotton, James Nuttall, Gadija Essack, Brad Karalius, George Seage, Shobna Sawry, Matthias Egger and Lee Fairlie for IeDEA Southern Africa. What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. Pediatric Infectious Disease Journal 2019, 38(4); 400-405.
   
• Mehta Ushma, Kalk Emma, Fairlie Lee, Boulle Andrew, Rees Helen. Why South Africa urgently needs to support the development of pregnancy exposure registries. South African Medical Journal 2019, 109(5); 294-295.

2014

• Leigh F. Johnson. THEMBISA Version 1.0: A model for evaluating the impact of HIV/AIDS in South Africa. Centre for Infectious Disease Epidemiology and Research working paper February 2014.
   

2011

• Leigh F. Johnson, Katharina Kranzer, Keren Middelkoop, Robin Wood. A model of the impact of HIV/AIDS and antiretroviral treatment in the Masiphumelele community. Centre for Infectious Disease Epidemiology and Research working paper June 2011.
   
• Khayelitsha 2001 - 2011 Summary Activity Report: 10 Years of HIV/TB Care At Primary Health Care Level. Médecins Sans Frontières, Western Cape Province Department of Health, City of Cape Town Department of Health, University of Cape Town, Centre for Infectious Disease Epidemiology and Research.
   
• Khayelitsha 2001 - 2011 Activity Report: 10 Years of HIV/TB Care At Primary Health Care Level. Médecins Sans Frontières, Western Cape Province Department of Health, City of Cape Town Department of Health, University of Cape Town, Centre for Infectious Disease Epidemiology and Research.
   
• Leigh F. Johnson & Andrew Boulle. Technical appendix to “How should access to antiretroviral treatment be measured?“ Published in the Bulletin of the World Health Organization. Centre for Infectious Disease Epidemiology and Research January 2011.
   

2010

• Osler, M., Boulle, A. Three Interlinked Electronic Registers (TIER.Net) Project: A working paper September 2010. Cape Town, University of Cape Town.
   
• Leigh Johnson. A model of paediatric HIV in South Africa. Centre for Infectious Disease Epidemiology and Research working paper December 2010.
   

2008

• Roundtable discussion on progress in the Western Cape Province in addressing HIV treatment needs: What does our data tell us? Minutes from meeting held on 15 April 2008.
   
• Schneider, H., van Rensburg, D. & Coetzee, D. Health systems and antiretroviral access: Key findings and policy recommendations. (2008), Bloemfontein, University of the Free State.
   
• Stinson, K., Myer, L. & Boulle, A. An evaluation of approaches to the initiation of antiretroviral therapy during pregnancy among HIV-infected women in Cape Town. (2008), Cape Town, University of Cape Town.
   
• Schneider, H., Boulle, A., Coetzee, D., Engelbrecht.M., Goudge, E., van Rensburg-Bonthuyzen, J., Pienaar, D. Models of care for antiretroviral service delivery in three provinces: Western Cape, Free State and Gauteng. (2008), Cape Town, University of Cape Town.
   

2006

• Pienaar D., Myer L., Cleary S., Coetzee D., Michaels D., Cloete K., Schneider H. & Boulle A. Models of Care for Antiretroviral Service Delivery. (2006). Cape Town, University of Cape Town.
   
• Osler, M., Bock, P., White, C., Cloete, K., Smuts, B., Slingers, N., Zweigenthal, V., Naidoo, P., Van Niekerk, L., Channing, L., Cragg, C., Kredo, T., Mehta, U., Naledi, T. & Boulle, A. The Western Cape Antiretroviral Programme: Monitoring Report. (2006), Cape Town, Provincial Government of the Western Cape.Bloemfontein, University of the Free State.